Early in the pandemic, countries like  South Korea and Taiwan  deployed contract tracing technologies to successfully contain the spread of COVID-19. This was not the case in the United States and Europe, where privacy concerns and the potential for misuse of personal information made people uncomfortable with mobile device-based technology that tracked their whereabouts, for example. Because of this
0 Comments
The investigational anti-PD-1 antibody sintilimab (Tyvyt, Innovent Biologics and Eli Lilly) has shown that it improves the efficacy of platinum-based chemotherapy in the first-line treatment of patients with advanced non-squamous non-small cell lung cancer (NSCLC) in a Chinese phase 3 trial dubbed ORIENT-11. The study was presented at the World Congress on Lung Cancer (WCLC)
0 Comments
Print this page SAN FRANCISCO, CA Aug 3, 2020 – Today, members of the COVID R&D Alliance AbbVie, Inc. (NYSE: ABBV), Amgen Inc. (NASDAQ: AMGN), and Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) announced the first patients enrolled in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID Therapeutic Response with Biomarker Integration and
0 Comments
August 5, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy August 05, 2020 — Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL listed in the table below to the consumer level. These products
0 Comments
Reviewed by Emily Henderson, B.Sc.Aug 10 2020 A new UC Davis Health study found that common gastrointestinal (GI) symptoms such as diarrhea, constipation and bloating are linked to troubling sleep problems, self-harm and physical complaints in preschool children. According to the study, published Aug. 6 in Autism Research, these GI symptoms are much more common
0 Comments
Hospitalizations due to e-cigarette and vaping-associated lung injury (EVALI) likely occurred years before last summer’s widely reported outbreak, new research suggests. A look-back analysis of hospital registry data from 2016 using ICD-10-CM coding guidance for EVALI enacted by the CDC this April, identified six cases that met the definition for the lung disorder, reported Kam
0 Comments
Indiana fell ill with a cough in early March, said her mother, Jane Evans. Although she didn’t have any other coronavirus symptoms, her parents kept her home for two weeks in line with government guidance. She was never ill enough to be hospitalized, her mother told CNN. Nonetheless, the teenager — who planned to audition
0 Comments
Education secretary Gavin Williamson says science will guide plans to reopen schools next month As we edge closer to the end of summer holidays, parents, teachers and children alike have been waiting to hear if, when and how they’ll be returning to school at the start of the academic year. The government has now said
0 Comments
Cannabidiol (CBD), the chemical found in the Cannabis sativa L plant, seems to be one of the most popular natural remedies on the market right now. Manufacturers are delivering CBD products in many ways, from capsules to lotions and rub-on balms, and a wide variety of edible products. One of the most trusted and dependable
0 Comments
A new test, the first to combine liquid biopsy and next generation sequencing (NGS), has been approved by the US Food and Drug Administration (FDA) for use in patients with metastatic nonsmall cell lung cancer (NSCLC) to identify tumors with specific mutation types of the epidermal growth factor receptor (EGFR) gene. The Guardant360 CDx assay (Guardant
0 Comments
Most of us are familiar with having to unbutton a tight pair of jeans after a slap-up meal. But for some people, bloating can be more regular, painful, and distressing. Here we share top tips for easing your digestive discomfort It’s normal to feel a little bloated and sluggish after overindulging, but some people are
0 Comments
Dr Gene Sung A group of experts representing various international professional societies has drafted a consensus statement on the determination of brain death or death by neurologic criteria (BD/DNC). The document, a result of the World Brain Death Project, surveys the clinical aspects of this determination, such as clinical testing, apnea testing, and the number
0 Comments
U.S. Speaker of the House Nancy Pelosi, joined by Senate Minority Leader Chuck Schumer, speaks to reporters in the U.S. Capitol in Washington, July 29, 2020. Erin Scott | Reuters Top Democrats on Sunday criticized President Donald Trump’s executive actions on coronavirus relief as “absurdly unconstitutional” and “way off base.” The measures, which Trump signed on Saturday
0 Comments
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells. The team’s SARS-BLOCK™ peptides competitively inhibit the receptor-binding domain (RBD) on the SARS-CoV-2 spike protein – the
0 Comments
FDA Approves Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older Print this page South San Francisco, CA — August 7, 2020 — Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Evrysdi (risdiplam) for treatment of
0 Comments
Endovascular treatment of vein of Galen aneurysmal malformation (VGAM) in babies with severe pulmonary hypertension can improve chances of survival, according to a study released today at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting. The study, Outcomes of Endovascular Treatment of Vein of Galen Aneurysmal Malformation in Neonates, evaluated data from 52 surgery
0 Comments
Welcome to this week’s edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the Web to help you learn what’s next. Lisa Grabl is president of the locum tenens division of CompHealth, the nation’s largest locum tenens physician staffing company and a leader in permanent and temporary allied healthcare
0 Comments
A new scientific statement from the American Heart Association (AHA) recommends incorporating a rapid diet-screening tool into routine primary care visits to inform dietary counseling and integrating the tool into patients’ electronic health record (EHR) platforms across all healthcare settings. The statement authors evaluated 15 existing screening tools and, although they did not recommend a
0 Comments
This content originally appeared on Sugar-Free Mom. Republished with permission. Salisbury steak is an easy ground beef patty, similar to hamburger steak, but closer to a meatloaf, in that it usually includes bread crumbs, onions, and eggs. It is always served with brown gravy and topped over mashed potatoes. To make a low-carb Salisbury steak,
0 Comments
These days, handwashing is more important than ever before. So how can we turn this necessary activity into a mindful moment? Once upon a time, hand washing was hardly a symbolic event. Rather, it was an unconscious reaction to, say, accidental contact with stray marmalade, taking out the bins, or petting a passing cat. But
0 Comments
The US Food and Drug Administration (FDA) has approved risdiplam (Evrysdi, Roche and PTC Therapeutics) for the treatment of adults and children at least 2 months old who have spinal muscular atrophy (SMA). This marks the first approval of an oral therapy for the rare and devastating condition. Risdiplam provides “an important treatment option for
0 Comments
Young elementary school students and their parents attempt to get the attention of passing motorists on Church Street in Winchester, MA on July 30, 2020. A group of Winchester parents hold an event on the town common, voicing their concerns about younger students being able to learn remotely and advocating for the full return of
0 Comments
Print this page GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) – Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M™ adjuvant in healthy adults 18-59 years of age. NVX‑CoV2373, the Company’s recombinant
0 Comments